ARTICLE | Clinical News
BerGenBio, Rigel preclinical data
January 20, 2014 8:00 AM UTC
In a mouse model of CML, twice-daily 25 mg BGB324 significantly improved survival vs. vehicle-treated controls (p<0.0001). BGB324 also significantly reduced leukemia cell burden as measured by differe...